United States · FDA National Drug Code directory

Members Mark Triple Antibiotic

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
68196-400_218dba30-8aa5-4e64-81c5-8a0be537b348
Product NDC
68196-400
Form
OINTMENT
Composition / generic term
bacitracin zinc, neomycin, polymyxin B
Labeler
Sam's West Inc
Marketing category
OTC MONOGRAPH DRUG
Marketing start / end (source format)
20240905
Source listing expiry
20261231

Source-listed ingredients

  • BACITRACIN ZINC — 400 [USP'U]/g
  • NEOMYCIN SULFATE — 3.5 mg/g
  • POLYMYXIN B SULFATE — 5000 [USP'U]/g

These values do not establish equivalence or a dose recommendation.

Packages

  • 3 TUBE in 1 CARTON (68196-400-21) / 28 g in 1 TUBE (68196-400-64) · 68196-400-21

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →
Members Mark Triple Antibiotic — United States | Molindra Medicines